Beijing, China

Jinqian Yu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinqian Yu. Retrieved from https://idiyas.com/inventor/jinqian-yu-nre2mid1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jinqian Yu: Innovator in Biological Alkaloids

Introduction

Jinqian Yu is a notable inventor based in Beijing, China. He has made significant contributions to the field of biological alkaloids, particularly in the development of derivatives that have therapeutic applications. His work focuses on addressing medical conditions such as ulcerative colitis.

Latest Patents

Jinqian Yu holds a patent for "Derivatives of protoberberine biological alkaloids and use of same inhibiting ulcerative colitis." This patent discloses derivatives of protoberberine biological alkaloids or physiologically acceptable salts produced through a derivative reaction of biological alkaline quaternary ammonium salts. The derivatives exhibit activity that inhibits ulcerative colitis and can be utilized in the preparation of related pharmaceuticals. He has 1 patent to his name.

Career Highlights

Throughout his career, Jinqian Yu has worked with prestigious institutions such as the Chinese Academy of Sciences and the Chinese Academy of Medical Sciences. His research has contributed to advancements in medical treatments and has garnered attention in the scientific community.

Collaborations

Jinqian Yu has collaborated with notable colleagues, including Hailin Qin and Wenjie Wang. These partnerships have facilitated the exchange of ideas and have enhanced the impact of his research.

Conclusion

Jinqian Yu's innovative work in the field of biological alkaloids demonstrates his commitment to advancing medical science. His contributions, particularly in developing treatments for ulcerative colitis, highlight the importance of research in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…